Literature DB >> 9817799

IGF-I and vanadate stimulate Na/Pi-cotransport in OK cells by increasing type II Na/Pi-cotransporter protein stability.

A W Jehle1, J Forgo, J Biber, E Lederer, R Krapf, H Murer.   

Abstract

Insulin-like growth factor (IGF)-I and vanadate increase Na-dependent phosphate (Na/Pi) cotransport in opossum kidney (OK) cells. To gain more information about the mechanisms by which IGF-I and vanadate stimulate Na/Pi-cotransport, we measured type II Na/Pi-cotransporter (NaPi-4) protein abundance by Western blot analysis and investigated the effects of protein synthesis and tyrosine kinase inhibitors. The key findings in the present studies are as follows. First, incubation in IGF-I (10(-8) M) and/or vanadate (10(-3) M) for 3 h led to a non-additive 1.4-fold increase in Na/Pi-cotransport activity which was paralleled by a 1.5- to 2-fold increase in NaPi-4 protein. Second, actinomycin D did not abolish the increase in Na/Pi-cotransport and cycloheximide did not prevent the IGF-I-induced increase in Na/Pi-cotransport and NaPi-4 protein. Third, among the protein kinase inhibitors tested, only staurosporine substantially reduced the stimulation of Na/Pi-cotransport. In conclusion, the stimulatory effect of IGF-I on Na/Pi-cotransport is paralleled by an increased expression of NaPi-4 protein that is independent of protein synthesis and therefore results from increased protein stability. The observation that IGF-I and/or vanadate lead to similar increases in Na/Pi-cotransport and NaPi-4 protein abundance provides further evidence that the stimulation of Na/Pi-cotransport by IGF-I and vanadate involves protein tyrosine phosphorylation of the same signalling molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817799     DOI: 10.1007/s004240050759

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  7 in total

1.  PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria.

Authors:  Michael Föller; Daniela S Kempe; Krishna M Boini; Ganesh Pathare; Balasaheb Siraskar; Paola Capuano; Ioana Alesutan; Mentor Sopjani; Gerti Stange; Nilufar Mohebbi; Madhuri Bhandaru; Teresa F Ackermann; Martin S Judenhofer; Bernd J Pichler; Jürg Biber; Carsten A Wagner; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

2.  Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF.

Authors:  Tatsiana Pakladok; Zohreh Hosseinzadeh; Aleksandra Lebedeva; Ioana Alesutan; Florian Lang
Journal:  J Membr Biol       Date:  2013-11-21       Impact factor: 1.843

Review 3.  The SLC34 family of sodium-dependent phosphate transporters.

Authors:  Carsten A Wagner; Nati Hernando; Ian C Forster; Jürg Biber
Journal:  Pflugers Arch       Date:  2013-12-19       Impact factor: 3.657

4.  Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3.

Authors:  Madhuri Bhandaru; Daniela S Kempe; Anand Rotte; Paola Capuano; Ganesh Pathare; Mentor Sopjani; Ioana Alesutan; Leonid Tyan; Dan Yang Huang; Balasaheb Siraskar; Martin S Judenhofer; Gerti Stange; Bernd J Pichler; Jürg Biber; Leticia Quintanilla-Martinez; Carsten A Wagner; David Pearce; Michael Föller; Florian Lang
Journal:  Kidney Int       Date:  2011-03-30       Impact factor: 10.612

5.  Growth hormone therapy in HHRH.

Authors:  Guido Filler; Clara Schott; Fabio Rosario Salerno; Andrea Ens; Christopher William McIntyre; Maria Esther Díaz González de Ferris; Robert Stein
Journal:  Bone Rep       Date:  2022-05-18

Review 6.  Growth Hormone and IGF1 Actions in Kidney Development and Function.

Authors:  Evgenia Gurevich; Yael Segev; Daniel Landau
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

7.  Renal effects of growth hormone in health and in kidney disease.

Authors:  Dieter Haffner; Andrea Grund; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.